(Q34203078)

English

Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

object named as

Guy Griebel

2

0 references

Catherine Belzung

object named as

Catherine Belzung

3

0 references

author name string

Cecile Ducottet

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

625-631

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticotrophin-releasing factor receptors: from molecular biology to drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of Fat and Protein Intakes But Not Carbohydrate Intake Following Acute and Chronic Fluoxetine in Female Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticotropin-releasing hormone in depression and post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alnespirone (S 20499), an agonist of 5-HT1A receptors, and imipramine have similar activity in a chronic mild stress model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Are CRF receptor antagonists potential antidepressants?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The validity of animal models of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic mild stress-induced anhedonia: a realistic animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900051-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0278-5846(03)00051-4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34203078&oldid=1975018544"